Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal
Go back to Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal| Alpine Management Systems, Inc. (NASDAQ: ALPN) | Delayed: 64.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.97 | 52 Week High | $0.00 | |||
| Open | $43.88 | 52 Week Low | $2156.81 | |||
| Day High | $64.97 | P/E | N/A | |||
| Day Low | $64.97 | EPS | $0.00 | |||
| Volume | 6,065 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 546.12 -11.84 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $557.96 | 52 Week High | $134.71 | |||
| Open | $549.50 | 52 Week Low | $73.31 | |||
| Day High | $556.99 | P/E | N/A | |||
| Day Low | $544.48 | EPS | $-1.98 | |||
| Volume | 803,526 | |||||
